Cellular metabolism · target hub
PDK2 (PDK2)
PDK2 is a Glycolysis / glucose uptake on the cellular metabolism axis. Validate function and tissue distribution with UniProt and primary literature. It is indexed under "Core glycolytic enzymes (flux & branching)" on our pathway page for antibodies, inhibitors, and assay guidance.
| Type / example | Domain / context (brief) |
|---|---|
| Enzyme activity | Catalytic or substrate-channel changes |
| Steroid output | Steroid profile / metabolite readouts |
| Rare variants | Sporadic variants—require validation |
Naming and prevalence vary by cohort and assay—annotate clinically with COSMIC, ClinVar, OncoKB, and datasheets; research context only.
Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.
Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.
Overexpression vs endogenous PDK2 can differ in dosage, splicing, and compartmentation—in organoids/PDX, record passage, matrix, and drug history.
Adds PDK2 keyword bias atop the 细胞代谢 antibody pool—if sparse, use presets above or global search.
This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.
Last reviewed: 2026-05-18
See the cellular metabolism hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.